Tweet Drug development is ageist and if you are over a certain age you may be excluded from trials. This study looks at relapsing remitting trials and says that if they examine older people they may need more people to detect a different. This study suggests 10 times more people are needed. Hrere they looked…
Online mental health treatment program improves depression and anxiety in people with MS
The post Online mental health treatment program improves depression and anxiety in people with MS appeared first on MS Australia. Source: www.msaustralia.org.au
Insights from inside the MS brain
The post Insights from inside the MS brain appeared first on MS Australia. Source: www.msaustralia.org.au
A caregiver’s perspective on selfless love and unseen labor
Using a sit-to-stand to help Jennifer transfer from her power wheelchair in the restroom is one of the many everyday moments that make independence possible. ‘I didn’t set out to become a caregiver.’ Like a lot of people, I stepped into the role of a caregiver because it was needed. Because it was part of…
Neurologist Kappos wins Dystel Prize for advancing MS research
Ludwig Kappos, MD, a neurologist and researcher at University Hospital in Basel, Switzerland, has been named the 2026 recipient of the John Dystel Prize for Multiple Sclerosis Research for his central role in advancing understanding and treatment of multiple sclerosis (MS) and monitoring of disease progression. The $40,000 prize, one of the highest honors in…
Making your voice matter
Speaking up is so important for anyone going through a chronic illness like MS. Being a self-advocate while going through MS can be so challenging, as individuals going through MS are often misunderstood. This misunderstanding often stems from the invisible … Continue reading → Source: blog.mymsaa.org
Finding strength in every step as I dance with multiple sclerosis
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
Another mess for Natalizumab biosimilar use
Tweet The documents that dictate how a drug is used is called the “label” or the “summary of product characteristics” in Europe or UK. Yesterday, there was a post about biosimilar natalizumab (Tyruko) and reference natailizumab (Tysabri). In the highlights of the paper ( Gelissen et al. Mult Scler Relat Disord. 2026;109:107147. It said •Discrepant…
Me-Too Natalizumab…. Does Holland have the West London Feeling?
Tweet When the patent of reference natalizumab (Tysabri) infusion ran out the makers brought out subcutaneous natalizumab (Tysabri) and encouraged the neuros to switch…It also allowed generic makers to make replicas of natalizumab, called a biosimilar because it isn’t identical. Along came the first biosimilar natalizumab (Tyruko) and NICE in their stupidity said switch every…
I trusted my gut, even after hearing I was ‘too young’ to have MS
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….